Pear Therapeutics

Thank you @SenatorShaheen, @SenCapito, @MarshaBlackburn, @CoryBooker, @repkevinhern, @RepThompson, @RepBillJohnson, and @DorisMatsui for your bipartisan support on this critical legislation.

Today, the bipartisan Access to Prescription Digital Therapeutics Act of 2023 (S. 723/ H.R. 1458) was reintroduced in Congress. If approved, this legislation could play a pivotal role in improving access to #PDTs. Learn more: bit.ly/AccessPDTs

On #InternationalWomensDay, we #EmbraceEquity and celebrate the women at Pear who continuously innovate to create potentially life-changing therapies for serious diseases like addiction and insomnia. #IWD2023

Join us 3/2 for a webinar where we'll be discussing prescription digital therapeutics (#PDTs) with Todd Wurtz, PA at Coastal Spine & Pain Center based in FL, where our #PDTs for SUD and OUD are on FL Medicaid's Preferred Drug List. Register: bit.ly/3ILdpbO

.@SXSW here we come! We’re looking forward to being on the ground in Austin where we’ll be talking about how we can make a real change in drug policy. Stop by to hear from @FirstLadyND, Dr. @LipiRoy and @NIDA deputy director, Dr. Wilson Compton. #TackleAddictionSXSW

Polysubstance use disorder is on the rise, indicating that more than ever, a one-size-fits-all approach to treatment may not be enough in the fight against addiction. Learn more about the changing landscape in this new report:

In 2021, 75% of 107K overdose deaths involved opioids. As the opioid use epidemic continues, we must continue work to put innovative treatment options like #PDTs into the hands of patients.

Caregivers are extraordinary, and we wouldn’t be here without you. But have you checked in on yourself lately? On #NationalCaregiversDay, take time to prioritize your mental and physical well-being and check out some tips from @CaregiverAlly.

What percentage of drug overdose deaths in the US involved opioids in 2021?

On #InternationalDayofWomenAndGirlsInScience we honor the women who have been integral to advancing the fields of medicine and technology. Diverse perspectives drive innovation, and we must ensure that women from all backgrounds are represented in #STEM. #LifeAtPear

The road to recovery can be difficult. Stigma can make it even harder. By changing perceptions around substance use and opioid use disorders, we can reduce stigma around this chronic disease and help people get the treatment they need. Learn more from @Shatterproof.

Only 1 in 3 Black adults in the US who need mental health care receive it due to several factors including stigma and structural barriers? We’re committed to changing how mental health treatment is delivered to help create a more equitable healthcare system. #BlackHistoryMonth

Substance use disorder (SUD) is a chronic condition. Unlike other common, chronic conditions like diabetes, heart disease, or asthma, SUD is stigmatized. To improve addiction care, we need to transform these negative perceptions.

Through our continued work with @BrightViewHlth, we’re increasing access to substance use disorder (SUD) and opioid use disorder (OUD) treatment for people in recovery. Learn about the expansion of BrightView's pilot program.

Underserved populations, including people living in rural communities and people of color, often experience difficulties accessing mental health care. Digital therapeutics, such as #PDTs, offer the opportunity to make care more equitable. Learn more.

#DYK chronic insomnia doesn’t just affect sleep patterns? The disorder is also correlated with increased rates of high blood pressure, heart disease and mental illnesses. Learn how prescription digital therapeutics (#PDTs) can help treat insomnia.

Our prescription digital therapeutics (#PDTs) for the treatment of substance use and opioid use disorders are now available to Florida Medicaid members. Learn how this coverage decision helps put care in the hands of people in recovery.

Prescription digital therapeutics (#PDTs) have the potential to reshape treatment for substance and opioid use disorders. Learn how we’re working to advance innovation in this space and bring care to people living with addiction.

We’re proud to announce that we’ve entered into an agreement with @DHCS_CA to expand access to behavioral treatment to help address the stimulant use disorder crisis in California. Learn more about this new pilot program: bit.ly/3QxXUGm